TipRanks
Advertisement
Advertisement
Geovax Labs Risk Profile Appears Stable, But Investors Should Watch for Emerging SEC-Disclosed Pressures
PremiumCompany AnnouncementsGeovax Labs Risk Profile Appears Stable, But Investors Should Watch for Emerging SEC-Disclosed Pressures
2M ago
GeoVax Labs Faces Nasdaq Noncompliance and Listing Risk
Premium
Company Announcements
GeoVax Labs Faces Nasdaq Noncompliance and Listing Risk
3M ago
CDC raises Ebola Congo outbreak response to highest level, Reuters reports
Premium
The Fly
CDC raises Ebola Congo outbreak response to highest level, Reuters reports
3M ago
Roth Capital ‘strongly’ agrees with GeoVax ending COVID-19 development
PremiumThe FlyRoth Capital ‘strongly’ agrees with GeoVax ending COVID-19 development
4M ago
GeoVax drops 11% to $3.24 after stopping COVID vaccine development
Premium
The Fly
GeoVax drops 11% to $3.24 after stopping COVID vaccine development
4M ago
GeoVax Labs files to sell 7.64M shares of common stock for holders
Premium
The Fly
GeoVax Labs files to sell 7.64M shares of common stock for holders
4M ago
GeoVax Labs price target lowered to $10 from $14 at Roth Capital
PremiumThe FlyGeoVax Labs price target lowered to $10 from $14 at Roth Capital
6M ago
GeoVax Labs files to sell 1.27M shares of common stock for holders
Premium
The Fly
GeoVax Labs files to sell 1.27M shares of common stock for holders
6M ago
GeoVax Labs files to sell 865,804 shares of common stock for holders
Premium
The Fly
GeoVax Labs files to sell 865,804 shares of common stock for holders
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―